Bixiye
QP42-18 Addition of Drugs to the Cystic Fibrosis Transmembrane Conductance Regulator PA with QL Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2591 - 2600 ee natiijooyinka 3604
Bixiye
QP48-18 Referral Create, Inquiry and Update Functions Available on Availity
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2018
Bixiye
QP54-18 Medical Drug Exclusion Lists Expanded to Include Synojoynt
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018
Bixiye
QP43-18 Addition of Drugs to the Oral Immunotherapy PA with QL Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP8-18 Effective January 1, 2018 FEP Standard Option Subscriber SNF Benefit
Taariikhda uu dhaqangalayo Barnaamijka: 05, Feb 2018
Bixiye
QP1-16 Changes to SecureBlue (MSHO) Prescription Drug Coverage
Taariikhda uu dhaqangalayo Barnaamijka: Jan 07, 2016
Bixiye
QP18-17 Reminder Regarding PCA Assessment Requests
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2017
Bixiye
QP5-17 Pharmacy Benefit Update - EpiPen, EpiPen Jr., Auvi-Q and Procysbi
Taariikhda uu dhaqangalayo Barnaamijka: Mar 06, 2017
Bixiye
QP55-18 New Drug - Epidiolex (cannabidiol) will Require Prior Authorization
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018
Bixiye
QP27-18 Post Service Claim Appeals
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 24, 2018